October 26, 2009 (FinancialWire) — Lightlake Therapeutics Inc. (OTCBB: LLTP) has appointed Dr Roger Crystal as CEO.

Crystal began his career as a medical doctor in 2002 and qualified as a surgeon in 2005, most recently at St Mary’s Hospital, London.

In his new role, Crystal will run Lightlake’s operations from its London headquarters, overseeing the firm’s clinical trials program and the bringing to market a new treatment for obesity and unhealthy eating habits, according to Lightlake.

London-based Lightlake Therapeutics is a drug discovery company developing solutions to combat human obesity.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.